Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Barrett Esophagus 15Esophageal Neoplasms 10Colorectal Neoplasms 10Rectal Neoplasms 7Adenocarcinoma Of Esophagus 7Stomach Neoplasms 6Colonic Neoplasms 5Gastroesophageal Reflux 4Colorectal Neoplasms, Hereditary Nonpolyposis 3Precancerous Conditions 2Pathologic Complete Response 2Esophageal Squamous Cell Carcinoma 2Carcinoma 2Adenomatous Polyposis Coli 2Adenocarcinoma 2Stomach Ulcer 1Stomach Diseases 1Recurrence 1Polyps 1Polyposis, Gastric 1Pancreatic Pseudocyst 1Neoplasms 1Metaplasia 1Locally Advanced Pancreatic Cancer 1Hyperplasia 1Gastroparesis 1Gastrointestinal Neoplasms 1Gastrointestinal Diseases 1Gastric Outlet Obstruction 1Fistula 1

Interventions

Colonoscopy 4eicosapentaenoic acid ethyl ester 1Ursodeoxycholic Acid 1Telemedicine 1Suppositories 1Radiotherapy 1Propofol 1Midazolam 1Folic Acid 1Fentanyl 1Fatty Acids, Omega-3 1Endoscopy 1Endoscopic Mucosal Resection 1Eicosapentaenoic Acid 1Docosahexaenoic Acids 1Diet 1Diagnosis 1Cholecystectomy 1Cholecalciferol 1Celecoxib 1Calcium Carbonate 1CVD protocol 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Polyps × Endoscopy × Gastrointestinal × Clear all
NCT00510692 2014-08-22

Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPA

S.L.A. Pharma AG

Phase 2/3 Completed
58 enrolled 12 charts
Gastrointestinal

Hyperplasia, Adenomatous Polyposis Coli, Polyps

Data powered by HemOnc (CC BY 4.0) Colophon âš¡